Soparkar Peter's Form 4 filing
Adverum Biotechnologies, Inc. (ADVM) · filed Apr 20, 2022
- Accession no.
- 0001209191-22-024977
- Filed
- Apr 20, 2022
- Trade date
- Apr 19, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $25.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Soparkar PeterCIK 0001736315 | Officer (See Remarks section) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | Common Stock | PPurchaseAcquired | +175 | $1.14 | +$199.5 | 258,806 | Direct | |
| Apr 19, 2022 | Common Stock | PPurchaseAcquired | +21,750 | $1.14 | +$24,795 | 280,556 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Operating Officer and Chief Legal Officer